Viramune®

DRUG2 trials

Sponsors

Boehringer Ingelheim, Ratiopharm GmbH

Conditions

HIV InfectionsHIV-1

Phase 1

Multiple Dose BE Study With Nevirapine 400mg PR Tablets

CompletedNCT02202005

Ratiopharm GmbHHIV-1

Start: 2014-08-31End: 2015-08-31Updated: 2015-08-25

Unknown Phase

Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens

CompletedNCT02191319

Boehringer IngelheimHIV Infections

Start: 2002-01-31Updated: 2014-07-16